Works about PEMETREXED

Results: 780
    1

    Systemic Antifolate Chemotherapy Does Not Select for Fluconazole-Resistant Candida : A Multicenter Clinical Study.

    Published in:
    Pathogens, 2025, v. 14, n. 6, p. 574, doi. 10.3390/pathogens14060574
    By:
    • Żyrek, Dawid;
    • Nowicka, Joanna;
    • Pajączkowska, Magdalena;
    • Paściak, Mariola;
    • Machnik, Katarzyna;
    • Werner, Tomasz;
    • Konieczny, Zygmunt;
    • Jędrzejczak, Piotr;
    • Raźniewska, Dominika;
    • Fijałkowska, Gabriela;
    • Piątek, Michał;
    • Radecka, Barbara;
    • Żyrek, Kinga;
    • Woźniak-Grygiel, Elżbieta;
    • Dzieńdziora-Urbińska, Iwona
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8

    Dose Escalation and Pharmacokinetic Study of Carboplatin plus Pemetrexed for Elderly Patients with Advanced Nonsquamous Non-Small-Cell Lung Cancer: Kumamoto Thoracic Oncology Study Group Trial 1002.

    Published in:
    Oncology, 2015, v. 88, n. 4, p. 201, doi. 10.1159/000369255
    By:
    • Sakata, Shinya;
    • Sasaki, Jiichiro;
    • Saeki, Sho;
    • Hamada, Akinobu;
    • Kishi, Hiroto;
    • Nakamura, Kazuyoshi;
    • Tanaka, Hideyuki;
    • Notsute, Daisuke;
    • Sato, Ryo;
    • Saruwatari, Koichi;
    • Iriki, Toyohisa;
    • Akaike, Kimitaka;
    • Fujii, Shinji;
    • Hirosako, Susumu;
    • Kohrogi, Hirotsugu
    Publication type:
    Article
    9

    Development of stable formulations of pemetrexed.

    Published in:
    Journal of Research in Pharmacy, 2024, v. 28, n. 5, p. 1516, doi. 10.29228/jrp.830
    By:
    • VORA, Pratik Ashwinbhai;
    • PATEL, Rakesh;
    • DHARAMSI, Abhay;
    • PATEL, Devanshu;
    • SHAH, Umang
    Publication type:
    Article
    10
    11
    12
    13
    14
    15

    The ASCENT Trial: a phase 2 study of induction and consolidation afatinib and chemoradiation with or without surgery in stage III EGFR-mutant NSCLC.

    Published in:
    Oncologist, 2024, v. 29, n. 7, p. 609, doi. 10.1093/oncolo/oyae107
    By:
    • Chang, Allison E B;
    • Piper-Vallillo, Andrew J;
    • Mak, Raymond H;
    • Lanuti, Michael;
    • Muzikansky, Alona;
    • Rotow, Julia;
    • Jänne, Pasi A;
    • Mino-Kenudson, Mari;
    • Swanson, Scott;
    • Wright, Cameron D;
    • Kozono, David;
    • Marcoux, Paul;
    • Piotrowska, Zofia;
    • Sequist, Lecia V;
    • Willers, Henning
    Publication type:
    Article
    16

    A Misleading Case of NTRK-Rearranged Papillary Thyroid Carcinoma.

    Published in:
    Oncologist, 2024, v. 29, n. 1, p. 84, doi. 10.1093/oncolo/oyad310
    By:
    • Germani, Marco Maria;
    • Boccaccio, Chiara;
    • Matrone, Antonio;
    • Molinaro, Eleonora;
    • Alì, Greta;
    • Giordano, Mirella;
    • Elisei, Rossella;
    • Fontanini, Gabriella;
    • Cremolini, Chiara
    Publication type:
    Article
    17
    18
    19

    Apatinib plus Chemotherapy as a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1640, doi. 10.1634/theoncologist.2020-0519
    By:
    • Yu, Zongyang;
    • Cai, Xiuyu;
    • Xu, Zhengwu;
    • He, Zhiyong;
    • Lai, Jinhuo;
    • Wang, Wenwu;
    • Zhang, Jing;
    • Kong, Wencui;
    • Huang, Xiaoyan;
    • Chen, Ying;
    • Shi, Yanhong;
    • Shi, Xi;
    • Zhao, Zhongquan;
    • Ni, Min;
    • Lin, Xiangwu;
    • Chen, Siyu;
    • Wu, Xiaolong;
    • Chen, Wujin;
    • Song, Zhengbo;
    • Huang, Cheng
    Publication type:
    Article
    20
    21

    Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy.

    Published in:
    Oncologist, 2020, v. 25, n. 3, p. e398, doi. 10.1634/theoncologist.2018-0883
    By:
    • Zubiri, Leyre;
    • Allen, Ian M.;
    • Taylor, Martin S.;
    • Guidon, Amanda C.;
    • Chen, Steven T.;
    • Schoenfeld, Sara R.;
    • Neilan, Tomas G.;
    • Sise, Meghan E.;
    • Mooradian, Meghan J.;
    • Rubin, Krista M.;
    • Leaf, Rebecca Karp;
    • Parikh, Aparna R.;
    • Faje, Alexander;
    • Gainor, Justin F.;
    • Cohen, Justine V.;
    • Fintelmann, Florian J.;
    • Kohler, Minna J.;
    • Dougan, Michael;
    • Reynolds, Kerry L.
    Publication type:
    Article
    22

    A Randomized, Double‐Blinded, Phase II Trial of Carboplatin and Pemetrexed with or without Apatorsen (OGX‐427) in Patients with Previously Untreated Stage IV Non‐Squamous‐Non‐Small‐Cell Lung Cancer: The SPRUCE Trial.

    Published in:
    Oncologist, 2019, v. 24, n. 12, p. e1409, doi. 10.1634/theoncologist.2018-0518
    By:
    • Spigel, David R.;
    • Shipley, Dianna L.;
    • Waterhouse, David M.;
    • Jones, Suzanne F.;
    • Ward, Patrick J.;
    • Shih, Kent C.;
    • Hemphill, Brian;
    • McCleod, Michael;
    • Whorf, Robert C.;
    • Page, Ray D.;
    • Stilwill, Joseph;
    • Mekhail, Tarek;
    • Jacobs, Cindy;
    • Burris, Howard A.;
    • Hainsworth, John D.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1348034
    By:
    • Shota Takei;
    • Hayato Kawachi;
    • Tadaaki Yamada;
    • Motohiro Tamiya;
    • Yoshiki Negi;
    • Yasuhiro Goto;
    • Akira Nakao;
    • Shinsuke Shiotsu;
    • Keiko Tanimura;
    • Takayuki Takeda;
    • Asuka Okada;
    • Taishi Harada;
    • Koji Date;
    • Yusuke Chihara;
    • Isao Hasegawa;
    • Nobuyo Tamiya;
    • Yuki Katayama;
    • Naoya Nishioka;
    • Kenji Morimoto;
    • Masahiro Iwasaku
    Publication type:
    Article
    34
    35
    36
    37

    Single-cell mass cytometric analysis of peripheral immunity and multiplex plasma marker profiling of non-small cell lung cancer patients receiving PD-1 targeting immune checkpoint inhibitors in comparison with platinum-based chemotherapy.

    Published in:
    Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1243233
    By:
    • Neuperger, Patrícia;
    • Szalontai, Klára;
    • Gémes, Nikolett;
    • Balog, József Á.;
    • Tiszlavicz, László;
    • Furák, József;
    • Lázár, György;
    • Puskás, László G.;
    • Szebeni, Gábor J.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45

    Tolerability and Outcomes of First-Line Pemetrexed-Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in Korean Patients with Advanced Nonsquamous Non-small Cell Lung Cancer: A Post Hoc Descriptive Subgroup Analysis of a Randomized, Phase 3 Trial

    Published in:
    Cancer Research & Treatment, 2016, v. 48, n. 2, p. 458, doi. 10.4143/crt.2015.135
    By:
    • Jin Hyoung Kang;
    • Myung-Ju Ahn;
    • Dong-Wan Kim;
    • Eun Kyung Cho;
    • Joo-Hang Kim;
    • Sang Won Shin;
    • Xin Wang;
    • Jong Seok Kim;
    • Mauro Orlando;
    • Keunchil Park
    Publication type:
    Article
    46
    47
    48
    49
    50